Atherosclerosis Begins Decades Before a Heart Attack. Most People Have No Idea It Is Already Progressing.

Atherosclerosis is the progressive buildup of plaques composed of oxidised lipids, immune cells, calcium, and fibrous tissue within the walls of arteries. It is the underlying structural disease behind the majority of heart attacks, strokes, and peripheral arterial disease. Atherosclerosis is not simply a consequence of high cholesterol or a fatty diet. It is an inflammatory disease of the arterial wall initiated by endothelial dysfunction, driven by oxidative stress and immune activation, and accelerated by insulin resistance, chronic inflammation, and metabolic dysfunction. Cholesterol is involved but it is a passenger in a process driven by inflammation, and not the primary cause. This distinction is critical because it determines what needs to be addressed to actually halt and reverse the process.

The process begins with endothelial dysfunction damage to the single cell layer lining the inside of arterial walls that is responsible for producing nitric oxide, regulating vascular tone, and maintaining a barrier against lipid infiltration. When this lining is damaged by oxidative stress, chronic inflammation, elevated insulin, smoking, or mechanical stress from hypertension such as LDL particles, particularly small dense oxidised ones, infiltrate the arterial wall. The immune system mounts a response sending macrophages to engulf the oxidised LDL. These macrophages become foam cells and accumulate forming fatty streaks that progressively enlarge into plaques. Over decades these plaques grow, calcify, and narrow the arterial lumen until a plaque ruptures triggering a clot that causes a heart attack or stroke.

‍

Fatty streaks, the earliest stage of atherosclerosis, have been found in the arteries of teenagers and young adults in autopsy studies. The process begins decades before symptoms appear and decades before any conventional cardiovascular risk assessment would trigger concern. The metabolic and inflammatory drivers including insulin resistance, endothelial dysfunction, oxidative stress, chronic inflammation begin operating in early adulthood and accumulate silently. By the time a person is told their cholesterol or blood pressure is concerning, arterial damage has typically been building for twenty to thirty years.

‍

Indians develop atherosclerosis and cardiovascular disease at younger ages, lower cholesterol levels, and lower body weights than Western populations. The genetic predisposition toward insulin resistance and atherogenic dyslipidaemia such as high triglycerides, low HDL, and small dense LDL combined with the rapid dietary transition toward refined carbohydrates, chronic psychological stress, widespread vitamin D deficiency, sedentary urban lifestyles, and high rates of metabolic syndrome create conditions in which atherosclerosis progresses faster and more severely than standard risk models predict. India has one of the highest rates of premature cardiovascular disease in the world and the majority of it traces back to addressable metabolic and inflammatory drivers.

‍

Atherosclerosis is managed as a cholesterol problem requiring lipid lowering medication. What it actually is is an inflammatory disease of the arterial wall driven by endothelial dysfunction, oxidative stress, insulin resistance, and chronic immune activation with cholesterol as one participant in a much more complex process. Statins reduce LDL and have modest anti-inflammatory effects. They do not restore endothelial function, do not correct insulin resistance, do not address oxidative stress, and do not resolve the chronic inflammation driving plaque progression. Address those drivers and atherosclerotic progression slows, stabilises, and in many cases partially reverses as demonstrated in well-conducted clinical trials of comprehensive lifestyle and nutritional intervention.

‍